5 Best Mid-Cap Stocks For 2021

In this article, we discuss the 5 best mid-cap stocks for 2021. If you want to read our detailed analysis of these stocks, go directly to the 15 Best Mid-Cap Stocks for 2021.

5. Alkermes plc (NASDAQ: ALKS)

Number of Hedge Fund Holders: 36

Alkermes plc (NASDAQ: ALKS) is a biopharmaceutical company with a focus on psychiatric and neurological disorders including schizophrenia as well as alcohol and opioid dependence. It is ranked fifth on our list of 15 best mid-cap stocks for 2021. The stock has returned over 88.98% to investors over the course of the past year.

On July 28, Alkermes plc (NASDAQ: ALKS) posted earnings for the second quarter of 2021, reporting earnings per share of $0.30, beating estimates by $0.18. The revenue over the period was around $304 million, up 22.70% year-over-year.

At the end of the second quarter of 2021, 36 hedge funds in the database of Insider Monkey held stakes worth $898 million in Alkermes plc (NASDAQ: ALKS), up from 31 the preceding quarter worth $596 million.

Out of the hedge funds tracked by Insider Monkey, Sarissa Capital Management has the most valubale stake in Alkermes plc (NASDAQ: ALKS) as of the end of the second quarter of 2021, worth close to $291 million, comprising 23.14% of its 13F portfolio.

On August 3, Mizuho reiterated its Buy rating on Alkermes plc (NASDAQ: ALKS) with a price target of $33, noting that the company will benefit from its cancer drug receiving FDA’s Fast Track designation.